Skip to main content

Balyasny Asset Management L.P.

Position in VCYT — Veracyte, Inc.

CIK 1218710 Chicago, IL

Position in VCYT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,629,340
+$8,600,642 QoQ
Shares Held
298,955
+897.7% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Derivatives in VCYT

reported options exposure · as of Sep 30, 2022
CallValue
$498,000
CallShares
30,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $561,999,836 across 19 Diagnostics & Research names. VCYT ranks #9 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VCYT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,629,340 298,955
2025-09-30 $1,028,698 29,965
2025-06-30 $4,601,803 170,248
2023-09-30 $2,281,634 102,178
2023-06-30 $571,470 22,437
2023-03-31 $1,104,741 49,540
2022-12-31 $3,962 167
2022-09-30 $300,443 18,099
2022-09-30 $498,000 30,000
2021-12-31 $7,932,483 192,536
2021-09-30 $10,382,132 223,512
2020-09-30 $7,178,730 220,952
2020-06-30 $6,668,965 257,489